To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RAB11FIP1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
429 supporting clones for gene RAB11FIP1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BU502420 mixed (pool of 40 RNAs) .a 1 to 665 9 to 687   available from MGC,   687/903
(76 %)
40 diff
(95.6 %id)
BX955251   .a 1 to 641 7 to 647       647/647
(100 %)
2 diff
(99.7 %id)
BF590604 colon, colon tumor, RER+ .a 1 to 242 250 to -5       250/260
(96 %)
6 diff
(97.7 %id)
DA451839 tongue, tumor tissue .a 1 to 532 7 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
BC054881 Pooled, 40 cell lines .a 1 to 692 10 to 699   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 695/701
(99 %)
11 diff
(98.5 %id)
DA457942 tongue, tumor tissue .a 1 to 479 6 to 484   capped   483/483
(100 %)
0 diff
(100 %id)
DA674906   .a 1 to 585 6 to 590   tiling clone, capped   589/589
(100 %)
0 diff
(100 %id)
DA710139   .a 1 to 534 6 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
DA725000   .a 1 to 558 6 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA844222 placenta .a 1 to 572 6 to 579   capped   578/578
(100 %)
3 diff
(99.5 %id)
DA937526 Spleen .a 1 to 548 6 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
DA962170 Spleen .a 1 to 550 6 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
DA990510 synovial membrane tissue from rheumatioidarthritis .a 1 to 544 6 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DB058111 testis .a 1 to 524 6 to 530   capped   529/529
(100 %)
1 diff
(99.9 %id)
DB239915 trachea .a 1 to 562 6 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DB239636 trachea .a 1 to 573 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DR005339 Prostate .a 2 to 598 8 to 604       597/604
(98 %)
6 diff
(99.1 %id)
BU527321 epidermoid carcinoma, cell line, lung .a 16 to 641 1 to 632       632/917
(68 %)
14 diff
(98.5 %id)
AY280968   .a 27 to 3892 1 to 3866 Q622K A651V M1185T tiling clone,   3866/3866
(100 %)
4 diff
(99.9 %id)
AA176111   .a 28 to 580 1 to 529       529/530
(99 %)
22 diff
(95.9 %id)
CN346607 embryonic stem cells, cell lines H1, H7, andH9 .a 40 to 677 1 to 638       638/638
(100 %)
0 diff
(100 %id)
AI678240 Prostate .a 47 to 272 226 to 1       226/226
(100 %)
4 diff
(98.3 %id)
AA622508 colon, colon tumor RER+ .a 66 to 293 218 to 1       218/218
(100 %)
12 diff
(94.5 %id)
BE900739 choriocarcinoma, placenta .a 264 to 839 1 to 579       579/662
(87 %)
32 diff
(95.2 %id)
BG149543 carcinoid, lung .a 285 to 637 1 to 353     Submitted on the opposite strand 353/353
(100 %)
2 diff
(99.5 %id)
AA913903 pooled .a 286 to 647 1 to 359     Submitted on the opposite strand 359/359
(100 %)
3 diff
(99.2 %id)
AW182156 pooled .a 286 to 725 1 to 441     Submitted on the opposite strand 441/441
(100 %)
4 diff
(99.1 %id)
BE676095 B-cell, chronic lymphotic leukemia .a 286 to 781 1 to 496     Submitted on the opposite strand 496/496
(100 %)
0 diff
(100 %id)
TI_157613795   .a 286 to 831 57 to 604     Submitted on the opposite strand 548/606
(90 %)
14 diff
(97.7 %id)
AW139653   .a 287 to 728 1 to 442     Submitted on the opposite strand 442/442
(100 %)
0 diff
(100 %id)
AK226111 brain .a 294 to 7834 1 to 7541   tiling clone, AAA   7541/7541
(100 %)
8 diff
(99.9 %id)
H02245 placenta .a 294 to 653 1 to 363     Submitted on the opposite strand 363/363
(100 %)
9 diff
(97.6 %id)
BM689496 eye, Retina Foveal and Macular .a 294 to 652 359 to 1     Submitted on the opposite strand 359/359
(100 %)
0 diff
(100 %id)
AI347926 adenocarcinoma, colon .a 304 to 795 1 to 493     Submitted on the opposite strand 493/493
(100 %)
4 diff
(99.2 %id)
AI393101 B-cell, chronic lymphotic leukemia .a 311 to 645 1 to 335     Submitted on the opposite strand 335/335
(100 %)
4 diff
(98.9 %id)
H84826 melanocyte .a 338 to 661 1 to 325     Submitted on the opposite strand 325/326
(99 %)
6 diff
(98.2 %id)
AA837142 germinal center B cell .a 352 to 753 1 to 399       399/399
(100 %)
3 diff
(99.3 %id)
AA829469 germinal center B cell .a 357 to 524 1 to 166     Submitted on the opposite strand 166/166
(100 %)
5 diff
(97.0 %id)
AA825549 germinal center B cell .a 361 to 643 1 to 279     Submitted on the opposite strand 279/279
(100 %)
4 diff
(98.6 %id)
DA590682 lung .a 411 to 541 432 to 562   capped   561/561
(100 %)
7 diff
(98.8 %id)
DA592618 lung .a 411 to 543 428 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
CB989063 Human Placenta, placenta .a 411 to 734 443 to 772       753/772
(97 %)
14 diff
(98.2 %id)
BP283044 bone marrow .a 411 to 568 425 to 582       582/582
(100 %)
0 diff
(100 %id)
NM_001002814.2   .a 411 to 7839 428 to 7856 exact RefSeq,   7856/7856
(100 %)
0 diff
(100 %id)
DA725630   .a 411 to 546 428 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA839113 placenta .a 411 to 537 429 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DA863672 placenta .a 411 to 558 425 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BP342894 stomach mucosa .a 411 to 562 428 to 579       579/579
(100 %)
1 diff
(99.9 %id)
DB134598 thymus .a 411 to 452 428 to 469   capped   468/470
(99 %)
2 diff
(99.6 %id)
DB219606 trachea .a 411 to 548 425 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BF987750 placenta_normal .a 502 to 755 1 to 254       254/254
(100 %)
6 diff
(97.7 %id)
CV368139 colon .a 530 to 712 184 to 3     Submitted on the opposite strand 182/184
(98 %)
0 diff
(100 %id)
CF138189 lymph .a 550 to 883 8 to 341       334/341
(97 %)
6 diff
(98.3 %id)
TI_154167996   .a 550 to 1048 80 to 578       499/499
(100 %)
4 diff
(99.2 %id)
AW381334 head_neck .a 567 to 1048 16 to 498       483/508
(95 %)
16 diff
(96.9 %id)
BU429704 lymph .a 570 to 1023 1 to 454       454/454
(100 %)
3 diff
(99.4 %id)
TI_154150820   .a 575 to 1331 77 to 839       763/779
(97 %)
40 diff
(94.9 %id)
AA122408 colon, tumor .a 594 to 984 1 to 392       392/392
(100 %)
1 diff
(99.8 %id)
CN346606 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 602 to 897 1 to 296       296/296
(100 %)
0 diff
(100 %id)
CN346611 embryonic stem cells, cell lines H1, H7, andH9 .a 605 to 1363 1 to 759       759/759
(100 %)
0 diff
(100 %id)
AW814782 stomach .a 623 to 763 147 to 3       145/147
(98 %)
0 diff
(100 %id)
CA314282 Human Lung Epithelial cells, lung .a 645 to 919 71 to 346     Submitted on the opposite strand 276/334
(82 %)
8 diff
(97.7 %id)
DA765102 tongue .a 677 to 1246 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA930518 small intestine .a 678 to 1122 2 to 448   capped   447/447
(100 %)
8 diff
(98.3 %id)
AA699588 liver and spleen .a 723 to 1280 579 to 23       557/579
(96 %)
0 diff
(100 %id)
AA704849 liver and spleen .a 754 to 1280 531 to 6       526/531
(99 %)
0 diff
(100 %id)
AW136796   .a 888 to 1361 24 to 497     Submitted on the opposite strand 474/497
(95 %)
6 diff
(98.8 %id)
BG013725 placenta_normal .a 927 to 1379 1 to 450       450/461
(97 %)
13 diff
(97.2 %id)
BG984314 colon_normal .a 939 to 1126 12 to 201       190/201
(94 %)
5 diff
(97.6 %id)
BE814626 breast_normal .a 1017 to 1393 1 to 374       374/376
(99 %)
6 diff
(98.5 %id)
AW390233 stomach .a 1055 to 1564 7 to 516       510/599
(85 %)
17 diff
(97.2 %id)
BM836445 Ascites, stomach .a 1222 to 1368 1 to 147       147/147
(100 %)
2 diff
(98.7 %id)
FN161031 breast carcinoma .a 1278 to 1379 99 to 1     Submitted on the opposite strand 99/99
(100 %)
3 diff
(97.0 %id)
AA137237 colon, tumor .a 1291 to 1659 1 to 370       370/370
(100 %)
3 diff
(99.2 %id)
CF137989 lymph .a 1377 to 1929 7 to 559       553/559
(98 %)
8 diff
(98.6 %id)
TI_154167701   .a 1377 to 2045 77 to 749   tiling clone,   673/833
(80 %)
14 diff
(98.4 %id)
R45907   .a 1486 to 1606 1 to 120       120/120
(100 %)
3 diff
(97.5 %id)
BX951691   .a 1829 to 2394 1 to 565       565/565
(100 %)
4 diff
(99.3 %id)
BF931188 nervous_tumor .a 1835 to 2214 392 to 10     Submitted on the opposite strand 383/392
(97 %)
0 diff
(100 %id)
AK122583 Spleen .a 1845 to 7834 1 to 5992   tiling clone, available from FLJ,   5992/5992
(100 %)
6 diff
(99.9 %id)
AW504705 lymph .a 2077 to 2491 1 to 415       415/415
(100 %)
4 diff
(99.1 %id)
TI_154160973   .a 2084 to 2742 72 to 719       648/714
(90 %)
15 diff
(97.9 %id)
CV394823 colon .a 2123 to 2235 1 to 116       116/130
(89 %)
6 diff
(95.4 %id)
BM806929 lymph, lymphoma, cell line .a 2133 to 2958 1 to 830       830/1055
(78 %)
16 diff
(98.5 %id)
CF121931 lymph .a 2346 to 2974 1 to 630       630/630
(100 %)
5 diff
(99.3 %id)
TI_154181298   .a 2352 to 3136 74 to 857       784/784
(100 %)
15 diff
(98.1 %id)
AL832155 human cervix .a 2402 to 5218 1 to 2817   available from DKFZ, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 2817/2817
(100 %)
9 diff
(99.7 %id)
BX951428   .a 2464 to 3154 54 to 744       691/744
(92 %)
6 diff
(99.2 %id)
AL833169 human cervix .a 2575 to 6116 1 to 3543   available from DKFZ, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 3543/3543
(100 %)
6 diff
(99.9 %id)
FN138772 breast carcinoma .a 2926 to 3015 88 to 1     Submitted on the opposite strand 88/88
(100 %)
2 diff
(97.8 %id)
BG983259 colon_normal .a 3167 to 3521 1 to 355       355/355
(100 %)
2 diff
(99.5 %id)
BE081795 breast .a 3217 to 3563 1 to 347       347/348
(99 %)
0 diff
(100 %id)
BX956602   .a 3223 to 3639 1 to 416       416/416
(100 %)
3 diff
(99.3 %id)
DA374855 thalamus .a 3352 to 3920 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
DB012407 esophageal, tumor tissue .a 3359 to 3848 2 to 492   capped   491/491
(100 %)
3 diff
(99.4 %id)
DA451002 tongue, tumor tissue .a 3382 to 3958 2 to 580   capped   579/579
(100 %)
4 diff
(99.4 %id)
DA563049 heart .a 3397 to 3969 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
BF327241 breast_normal .a 3430 to 3635 211 to 4       208/211
(98 %)
1 diff
(99.6 %id)
CN419852 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3431 to 3732 1 to 302       302/302
(100 %)
2 diff
(99.4 %id)
CR991916 T-Lymphocytes .a 3496 to 4153 1 to 658   tiling clone,   658/658
(100 %)
0 diff
(100 %id)
H02342 placenta .a 3582 to 4019 449 to 5     Submitted on the opposite strand 445/452
(98 %)
12 diff
(97.4 %id)
BE081470 breast .a 3583 to 4084 502 to 1     Submitted on the opposite strand 502/502
(100 %)
8 diff
(98.5 %id)
AK026177   .a 3645 to 5218 1 to 1574   available from FLJ, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 1574/1574
(100 %)
2 diff
(99.9 %id)
DA876254 Prostate .a 3697 to 4285 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
CN346605 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 3750 to 4050 1 to 300       300/300
(100 %)
2 diff
(99.4 %id)
BX951251   .a 3758 to 4267 1 to 510       510/510
(100 %)
0 diff
(100 %id)
BF511385   .a 3774 to 4078 323 to 18   AAA   306/316
(96 %)
1 diff
(99.7 %id)
BP302975   .a 3784 to 4333 1 to 552       552/552
(100 %)
6 diff
(99.0 %id)
BG960248 colon .a 3794 to 3975 184 to 5       180/184
(97 %)
0 diff
(100 %id)
AA305313 colon .a 3901 to 4245 1 to 345       345/345
(100 %)
0 diff
(100 %id)
AW955485   .a 3909 to 4540 1 to 630       630/634
(99 %)
16 diff
(97.5 %id)
BE081687 breast .a 3911 to 4500 596 to 8     Submitted on the opposite strand 589/596
(98 %)
0 diff
(100 %id)
DA829370 placenta .a 3918 to 4599 2 to 690   capped   689/794
(86 %)
8 diff
(99.0 %id)
DB111000 thymus .a 3996 to 4570 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
AW503772 lymph .a 4005 to 4458 1 to 454       454/454
(100 %)
5 diff
(98.9 %id)
AA581197 bulk tumor, colon .a 4011 to 4159 91 to 239       221/239
(92 %)
20 diff
(91.7 %id)
TI_154159790   .a 4012 to 4491 85 to 564       480/481
(99 %)
1 diff
(99.8 %id)
CN419854 embryonic stem cells, DMSO-treated H9 cellline .a 4064 to 4695 1 to 632       632/632
(100 %)
0 diff
(100 %id)
AW673450 cervix .a 4065 to 4427 1 to 362       362/362
(100 %)
1 diff
(99.8 %id)
DA850531 placenta .a 4072 to 4641 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
BE001580 breast_normal .a 4075 to 4244 170 to 1     Submitted on the opposite strand 170/172
(98 %)
11 diff
(93.7 %id)
DB211574 trachea .a 4126 to 4581 2 to 457   capped   456/456
(100 %)
1 diff
(99.8 %id)
DB249424 uterus .a 4129 to 4687 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BQ325266 colon_ins .a 4141 to 4597 8 to 463       456/463
(98 %)
7 diff
(98.5 %id)
BM829332 Ascites, stomach .a 4175 to 4409 1 to 235       235/235
(100 %)
4 diff
(98.3 %id)
AA308289 colon .a 4247 to 4372 10 to 135       126/135
(93 %)
5 diff
(96.3 %id)
FN059483 breast carcinoma .a 4299 to 4367 1 to 69       69/69
(100 %)
3 diff
(95.7 %id)
BE082006 breast .a 4377 to 4489 114 to 2     Submitted on the opposite strand 113/115
(98 %)
0 diff
(100 %id)
BI088983 cervix .a 4393 to 5165 1 to 773       773/882
(87 %)
20 diff
(97.8 %id)
DA232457 brain .a 4401 to 4975 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA813952   .a 4401 to 4953 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA183806 amygdala .a 4402 to 4965 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA183826 amygdala .a 4402 to 4953 2 to 555   capped   554/554
(100 %)
3 diff
(99.5 %id)
AA376768 small intestine .a 4430 to 4640 1 to 212       212/212
(100 %)
1 diff
(99.6 %id)
CN419851 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 4432 to 5030 1 to 599       599/603
(99 %)
1 diff
(99.9 %id)
AA121086 Pancreas .a 4441 to 4852 1 to 415       415/415
(100 %)
4 diff
(99.1 %id)
BU754126 placenta .a 4445 to 4902 654 to 196   AAA   459/636
(72 %)
0 diff
(100 %id)
AA102312 colon, tumor .a 4451 to 4830 1 to 385   fully sequenced,   385/385
(100 %)
1 diff
(99.8 %id)
AW958182   .a 4452 to 4993 1 to 541       541/541
(100 %)
22 diff
(96.0 %id)
N44159 melanocyte .a 4459 to 4732 1 to 276       276/276
(100 %)
3 diff
(99.0 %id)
BM796712 Ascites, stomach .a 4513 to 4894 1 to 384       384/384
(100 %)
3 diff
(99.3 %id)
CN419853 embryonic stem cells, cell lines H1, H7, andH9 .a 4554 to 5163 1 to 610       610/610
(100 %)
2 diff
(99.7 %id)
DA838543 placenta .a 4630 to 5199 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
AJ714875 bone marrow .a 4632 to 4897 1 to 264       264/264
(100 %)
6 diff
(97.8 %id)
DB325443 tongue .a 4647 to 5228 582 to 1       582/582
(100 %)
0 diff
(100 %id)
CN401529 embryonic stem cells, DMSO-treated H9 cellline .a 4659 to 5344 1 to 686       686/686
(100 %)
0 diff
(100 %id)
BE544375 cervical carcinoma cell line, cervix .a 4669 to 5343 1 to 672       672/672
(100 %)
9 diff
(98.7 %id)
TI_154168022   .a 4702 to 5201 578 to 80     Submitted on the opposite strand 499/499
(100 %)
4 diff
(99.2 %id)
DW431044 Liver .a 4717 to 4979 7 to 269       263/270
(97 %)
6 diff
(97.8 %id)
DW443428 Liver .a 4717 to 4940 7 to 230       224/230
(97 %)
5 diff
(97.9 %id)
AI858272 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 4725 to 5229 505 to 1       505/505
(100 %)
0 diff
(100 %id)
CX866789 embryonic stem .a 4734 to 5568 1 to 835       835/838
(99 %)
2 diff
(99.8 %id)
AA587215 colon, colon tumor RER+ .a 4737 to 5231 495 to 1       495/495
(100 %)
1 diff
(99.8 %id)
AA135360 colon, tumor .a 4744 to 5226 483 to 1       483/483
(100 %)
3 diff
(99.4 %id)
CF138161 lymph .a 4747 to 5201 462 to 8     Submitted on the opposite strand 455/462
(98 %)
0 diff
(100 %id)
TI_154159812   .a 4749 to 5218 569 to 99   AAA Submitted on the opposite strand 471/472
(99 %)
11 diff
(97.7 %id)
DA861152 placenta .a 4762 to 5346 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
N36169 melanocyte .a 4774 to 5228 463 to 1       463/464
(99 %)
16 diff
(96.6 %id)
AI290208 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4792 to 5229 438 to 1       438/438
(100 %)
2 diff
(99.6 %id)
AA102335 colon, tumor .a 4800 to 5228 431 to 1   fully sequenced,   431/431
(100 %)
4 diff
(99.1 %id)
AA122310 colon, tumor .a 4807 to 5229 426 to 1       426/433
(98 %)
2 diff
(99.6 %id)
BE243078 leukopheresis .a 4813 to 5218 406 to 1       406/406
(100 %)
5 diff
(98.8 %id)
DB374163 placenta .a 4830 to 5228 399 to 1       399/399
(100 %)
3 diff
(99.3 %id)
BM994124 lung, Metastatic Chondrosarcoma .a 4845 to 5233 392 to 4       389/392
(99 %)
0 diff
(100 %id)
AW503811 lymph .a 4856 to 5218 383 to 21   AAA Submitted on the opposite strand 363/363
(100 %)
1 diff
(99.8 %id)
AA122340 Pancreas .a 4957 to 5228 272 to 1       272/274
(99 %)
0 diff
(100 %id)
DB165525 thymus .a 5016 to 5558 2 to 545   capped   544/544
(100 %)
2 diff
(99.7 %id)
BM828616 Ascites, stomach .a 5093 to 5681 1 to 590       590/590
(100 %)
1 diff
(99.9 %id)
BM461675 leiomyosarcoma, uterus .a 5112 to 5793 25 to 706       682/985
(69 %)
18 diff
(98.2 %id)
CN258892 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 5141 to 5612 36 to 508       473/508
(93 %)
6 diff
(98.9 %id)
AA216644 brain, neuroepithelial cells .a 5170 to 5567 1 to 403       403/407
(99 %)
12 diff
(97.1 %id)
DA158342 amygdala .a 5178 to 5742 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
BF229162 amnion_normal .a 5180 to 5536 362 to 6       357/362
(98 %)
0 diff
(100 %id)
AW294925   .a 5196 to 5663 1 to 468     Submitted on the opposite strand 468/468
(100 %)
5 diff
(99.0 %id)
BI224169 cervical carcinoma cell line, cervix .a 5203 to 5797 2 to 608       607/774
(78 %)
42 diff
(94.6 %id)
BM825908 Ascites, stomach .a 5236 to 5488 1 to 253       253/446
(56 %)
4 diff
(99.2 %id)
BG493614 lung, mucoepidermoid carcinoma .a 5242 to 5888 1 to 657       657/857
(76 %)
48 diff
(94.4 %id)
TI_154136571   .a 5286 to 6112 876 to 56   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 821/1191
(68 %)
35 diff
(97.1 %id)
BM193884 leukopheresis .a 5348 to 5667 1 to 319       319/335
(95 %)
12 diff
(96.5 %id)
DA734798   .a 5358 to 6037 2 to 684   capped   683/705
(96 %)
11 diff
(98.5 %id)
DA750812   .a 5364 to 5929 2 to 567   capped   566/567
(99 %)
2 diff
(99.7 %id)
AL597103   .a 5382 to 5944 1 to 564       564/564
(100 %)
3 diff
(99.5 %id)
TI_154160610   .a 5407 to 6097 762 to 84     Submitted on the opposite strand 679/699
(97 %)
41 diff
(94.2 %id)
BM759501 Ascites, stomach .a 5415 to 6035 1 to 619       619/619
(100 %)
2 diff
(99.7 %id)
BF358241 lung_normal .a 5422 to 5596 1 to 176       176/182
(96 %)
10 diff
(94.6 %id)
AI279131 carcinoid, lung .a 5453 to 5802 377 to 28       350/377
(92 %)
0 diff
(100 %id)
FN054810 breast carcinoma .a 5480 to 5589 113 to 1     Submitted on the opposite strand 113/113
(100 %)
3 diff
(97.4 %id)
TI_154153532   .a 5505 to 6112 705 to 98   AAA Submitted on the opposite strand 608/608
(100 %)
0 diff
(100 %id)
AA523335 metastatic prostate bone lesion .a 5593 to 6119 531 to 7       525/536
(97 %)
0 diff
(100 %id)
TI_154136667   .a 5594 to 6112 582 to 62   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 521/1132
(46 %)
34 diff
(97.0 %id)
AK090578   .a 5597 to 7834 2265 to 28   available from FLJ, AAA Submitted on the opposite strand 2238/2238
(100 %)
5 diff
(99.8 %id)
DB295622   .a 5597 to 6141 1 to 545     Submitted on the opposite strand 545/545
(100 %)
2 diff
(99.7 %id)
DA634807 Kidney .a 5600 to 6178 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
AI718039 aorta .a 5603 to 6110 508 to 1       508/508
(100 %)
4 diff
(99.3 %id)
BU431634 lymph .a 5612 to 6112 526 to 26   AAA Submitted on the opposite strand 501/501
(100 %)
0 diff
(100 %id)
AU185773 skin .a 5614 to 6262 655 to 1       655/660
(99 %)
41 diff
(93.8 %id)
AI298302 carcinoid, lung .a 5615 to 6063 449 to 1       449/449
(100 %)
1 diff
(99.8 %id)
BF434214 Kidney .a 5618 to 6118 501 to 1       501/501
(100 %)
1 diff
(99.9 %id)
AW675772 cervix .a 5621 to 6119 499 to 1       499/499
(100 %)
1 diff
(99.8 %id)
FN088556 breast carcinoma .a 5630 to 5705 1 to 76       76/76
(100 %)
3 diff
(96.1 %id)
AW504461 lymph .a 5639 to 6097 466 to 8     Submitted on the opposite strand 459/466
(98 %)
0 diff
(100 %id)
AA573431 colon .a 5646 to 6117 472 to 1       472/472
(100 %)
0 diff
(100 %id)
CA309188 Alveolar Macrophage, lung .a 5663 to 6444 777 to 1   tiling clone,   777/778
(99 %)
0 diff
(100 %id)
AA157727 colon, tumor .a 5665 to 6070 1 to 406       406/406
(100 %)
2 diff
(99.6 %id)
BX506166   .a 5668 to 6169 1 to 502       502/502
(100 %)
2 diff
(99.7 %id)
AI719848 aorta .a 5687 to 6112 425 to 1       425/425
(100 %)
4 diff
(99.1 %id)
AA101293 brain, neuroepithelial cells .a 5712 to 6108 1 to 397       397/398
(99 %)
2 diff
(99.5 %id)
AI420820 Prostate .a 5768 to 6112 345 to 1       345/345
(100 %)
0 diff
(100 %id)
FN107095 breast carcinoma .a 5790 to 5887 96 to 1     Submitted on the opposite strand 96/99
(96 %)
3 diff
(97.0 %id)
W40578 Pancreas, pancreatic islet .a 5794 to 6118 1 to 325       325/325
(100 %)
10 diff
(97.0 %id)
BM837577 Ascites, stomach .a 5798 to 6425 1 to 628       628/628
(100 %)
4 diff
(99.4 %id)
TI_154154253   .a 5800 to 6425 736 to 113   AAA Submitted on the opposite strand 624/625
(99 %)
35 diff
(94.4 %id)
TI_154092709   .a 5802 to 6450 733 to 74       660/1024
(64 %)
0 diff
(100 %id)
W40576 Pancreas, pancreatic islet .a 5813 to 6118 306 to 1       306/306
(100 %)
10 diff
(96.8 %id)
BM828040 Ascites, stomach .a 5818 to 6328 1 to 512       512/512
(100 %)
6 diff
(98.9 %id)
BP417999 small intestine .a 5819 to 6312 1 to 496     Submitted on the opposite strand 496/496
(100 %)
3 diff
(99.4 %id)
CA942687 Pancreas, Purified pancreatic islet .a 5828 to 6424 597 to 1       597/597
(100 %)
1 diff
(99.9 %id)
DB255227 uterus .a 5830 to 6395 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
DA670453   .a 5833 to 6400 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
CA439087 lung, Lung Focal Fibrosis .a 5842 to 6425 9 to 592   AAA Submitted on the opposite strand 584/592
(98 %)
6 diff
(99.0 %id)
T08661   .a 5849 to 6269 1 to 424       424/424
(100 %)
4 diff
(99.1 %id)
CA867938 Pancreas, Purified pancreatic islet .a 5889 to 6433 1 to 545       545/545
(100 %)
0 diff
(100 %id)
BM759587 Ascites, stomach .a 5900 to 6295 1 to 396       396/396
(100 %)
1 diff
(99.8 %id)
CN365988 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 5901 to 6425 9 to 533   AAA   525/533
(98 %)
6 diff
(98.9 %id)
AI742968 pooled .a 5903 to 6427 525 to 1       525/525
(100 %)
2 diff
(99.7 %id)
DN997406 breast cancer, Mammary gland (cancer tissue) .a 5926 to 6516 24 to 615       592/615
(96 %)
6 diff
(99.1 %id)
T10598   .a 5946 to 6119 181 to 5       177/181
(97 %)
0 diff
(100 %id)
BU674058 lung, Primary Lung Epithelial Cells .a 5950 to 6117 186 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 168/168
(100 %)
5 diff
(97.1 %id)
T94977 lung .a 5976 to 6117 153 to 12   AAA Submitted on the opposite strand 142/142
(100 %)
0 diff
(100 %id)
T63377.
matches multiple genes
lung .a 5979 to 6124 1 to 146     also hits gene SHBandMCART1andEXOSC3 146/146
(100 %)
0 diff
(100 %id)
AW503664 lymph .a 5995 to 6427 26 to 458       433/458
(94 %)
6 diff
(98.7 %id)
TI_154159579   .a 5995 to 6430 110 to 547       438/665
(65 %)
5 diff
(99.3 %id)
BQ083449 stomach .a 6011 to 6117 1 to 107   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 107/107
(100 %)
0 diff
(100 %id)
AA971633 carcinoid, lung .a 6031 to 6430 399 to 1       399/399
(100 %)
3 diff
(99.3 %id)
BX415918 thymus .a 6036 to 7094 1 to 1051       1051/1051
(100 %)
65 diff
(93.9 %id)
AW500122 lymph .a 6045 to 6425 421 to 41   AAA Submitted on the opposite strand 381/381
(100 %)
1 diff
(99.8 %id)
TI_154136709   .a 6046 to 6425 438 to 60   AAA   379/1140
(33 %)
4 diff
(99.7 %id)
CA434598 lung, Lung Focal Fibrosis .a 6058 to 6444 386 to 1       386/386
(100 %)
0 diff
(100 %id)
BC001314 Placenta, choriocarcinoma .a 6112 to 7834 1 to 1723   available from MGC, AAA   1723/1723
(100 %)
2 diff
(99.9 %id)
BE538347 cervix .a 6133 to 6769 1 to 651   available from MGC,   651/671
(97 %)
21 diff
(96.9 %id)
BF036438 adenocarcinoma, ovary .a 6245 to 7015 1 to 776       776/838
(92 %)
14 diff
(98.4 %id)
CF594004 Human Placenta, placenta .a 6373 to 7134 29 to 790       762/792
(96 %)
5 diff
(99.4 %id)
TI_149305412   .a 6375 to 7241 94 to 947     Submitted on the opposite strand 854/1019
(83 %)
28 diff
(97.3 %id)
BF090453 nervous_tumor .a 6389 to 6568 1 to 179       179/185
(96 %)
12 diff
(93.6 %id)
BQ344150 nervous_tumor .a 6391 to 6568 1 to 182       182/186
(97 %)
15 diff
(92.0 %id)
AA148177 colon, tumor .a 6431 to 6691 1 to 265       265/266
(99 %)
8 diff
(97.0 %id)
BU569304 testis .a 6439 to 7206 1 to 769       769/769
(100 %)
5 diff
(99.4 %id)
AA501786 liposarcoma .a 6447 to 6684 8 to 245       238/245
(97 %)
6 diff
(97.6 %id)
BE378546 endometrium, adenocarcinoma cell line, uterus .a 6459 to 6976 1 to 519       519/519
(100 %)
1 diff
(99.9 %id)
AA465134 germinal center B cell .a 6488 to 6683 1 to 196       196/196
(100 %)
3 diff
(98.5 %id)
BE003143 breast_normal .a 6494 to 6834 345 to 2     Submitted on the opposite strand 344/345
(99 %)
0 diff
(100 %id)
BM837507 Ascites, stomach .a 6494 to 7187 1 to 694       694/694
(100 %)
3 diff
(99.6 %id)
AA021065 eye, retina .a 6558 to 6919 1 to 368       368/394
(93 %)
10 diff
(97.5 %id)
BE547625 cervical carcinoma cell line, cervix .a 6570 to 6995 179 to 605       427/610
(70 %)
8 diff
(98.7 %id)
AW390678 stomach .a 6573 to 7081 1 to 510       510/510
(100 %)
7 diff
(98.7 %id)
D79177 placenta .a 6577 to 6881 1 to 306       306/306
(100 %)
1 diff
(99.7 %id)
AW372211 breast .a 6583 to 7167 1 to 584       584/586
(99 %)
3 diff
(99.5 %id)
AW372198 breast .a 6585 to 7174 1 to 588       588/598
(98 %)
5 diff
(99.2 %id)
H44639 breast .a 6598 to 7019 1 to 423       423/423
(100 %)
1 diff
(99.8 %id)
AW749075 breast .a 6602 to 6883 287 to 4       284/297
(95 %)
0 diff
(100 %id)
N24394 melanocyte .a 6614 to 7094 1 to 481       481/483
(99 %)
1 diff
(99.8 %id)
FN144078 breast carcinoma .a 6616 to 6711 1 to 96       96/96
(100 %)
0 diff
(100 %id)
BP428659   .a 6644 to 7034 1 to 391       391/391
(100 %)
3 diff
(99.3 %id)
BM828770 Ascites, stomach .a 6738 to 7336 1 to 599       599/599
(100 %)
3 diff
(99.5 %id)
BP425961 small intestine .a 6783 to 7078 1 to 296     Submitted on the opposite strand 296/296
(100 %)
1 diff
(99.7 %id)
BF756994 colon .a 6789 to 7010 237 to 11     Submitted on the opposite strand 227/241
(94 %)
0 diff
(100 %id)
AW139467   .a 6801 to 7200 423 to 24       400/423
(94 %)
0 diff
(100 %id)
BF884216 lung_tumor .a 6802 to 7113 315 to 5     Submitted on the opposite strand 311/315
(98 %)
0 diff
(100 %id)
AW363178 colon .a 6825 to 7169 1 to 348       348/348
(100 %)
10 diff
(97.2 %id)
AW604647 colon .a 6854 to 7170 362 to 44       319/362
(88 %)
0 diff
(100 %id)
FN057544 breast carcinoma .a 6870 to 6958 94 to 1     Submitted on the opposite strand 94/95
(98 %)
9 diff
(90.6 %id)
AW604629 colon .a 6871 to 7169 5 to 297       293/297
(98 %)
6 diff
(98.0 %id)
BQ962652 leiomyosarcoma, uterus .a 6959 to 7819 1 to 875   tiling clone,   875/891
(98 %)
17 diff
(98.1 %id)
FN153151 breast carcinoma .a 6964 to 7034 67 to 1     Submitted on the opposite strand 67/70
(95 %)
7 diff
(90.0 %id)
R78337 placenta .a 6975 to 7412 1 to 449       449/493
(91 %)
14 diff
(97.2 %id)
AA340274 brain .a 6988 to 7419 1 to 438       438/438
(100 %)
8 diff
(98.2 %id)
AW964784   .a 6989 to 7508 1 to 520       520/521
(99 %)
1 diff
(99.9 %id)
AW964786   .a 6989 to 7262 1 to 278       278/282
(98 %)
16 diff
(94.4 %id)
FN082933 breast carcinoma .a 7000 to 7088 88 to 1     Submitted on the opposite strand 88/88
(100 %)
2 diff
(97.8 %id)
BE836715 prostate_normal .a 7021 to 7193 1 to 174       174/185
(94 %)
9 diff
(95.2 %id)
EC452036 Prostate .a 7055 to 7152 1 to 94       94/94
(100 %)
6 diff
(93.7 %id)
AW369487 breast_normal .a 7057 to 7242 11 to 203       193/203
(95 %)
6 diff
(97.1 %id)
AW861417 colon .a 7082 to 7286 217 to 12       206/217
(94 %)
0 diff
(100 %id)
BF875004 lung_tumor .a 7083 to 7519 456 to 19     Submitted on the opposite strand 438/457
(95 %)
0 diff
(100 %id)
BM976386 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 7119 to 7837 733 to 16   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 718/733
(97 %)
0 diff
(100 %id)
BQ774256 Chondrosarcoma Grade II, Left Pelvis .a 7120 to 7837 732 to 16   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 717/732
(97 %)
0 diff
(100 %id)
TI_149282687   .a 7126 to 7834 723 to 17   AAA   707/709
(99 %)
8 diff
(98.9 %id)
BF223517 carcinoid, lung .a 7127 to 7685 4 to 563     Submitted on the opposite strand 560/563
(99 %)
6 diff
(99.0 %id)
BF989700 placenta_normal .a 7136 to 7511 376 to 1       376/376
(100 %)
3 diff
(99.3 %id)
AI697987 carcinoid, lung .a 7143 to 7683 1 to 539     Submitted on the opposite strand 539/539
(100 %)
4 diff
(99.3 %id)
BE220138 carcinoid, lung .a 7143 to 7683 1 to 541     Submitted on the opposite strand 541/541
(100 %)
0 diff
(100 %id)
AW576849 breast .a 7150 to 7783 637 to 10       628/639
(98 %)
0 diff
(100 %id)
EC457087 Prostate .a 7158 to 7246 1 to 89       89/90
(98 %)
1 diff
(98.9 %id)
EC557980 Prostate .a 7159 to 7246 1 to 88       88/89
(98 %)
1 diff
(98.9 %id)
BG149631 carcinoid, lung .a 7160 to 7695 1 to 536     Submitted on the opposite strand 536/536
(100 %)
0 diff
(100 %id)
BF876025 lung_tumor .a 7174 to 7511 339 to 1     Submitted on the opposite strand 339/339
(100 %)
2 diff
(99.5 %id)
CB069834 Pancreas, Purified pancreatic islet .a 7191 to 7567 1 to 377   fully sequenced,   377/377
(100 %)
0 diff
(100 %id)
AA143793 colon, tumor .a 7194 to 7834 641 to 1       641/641
(100 %)
24 diff
(96.3 %id)
CA438589 lung, Metastatic Chondrosarcoma .a 7214 to 7837 638 to 16   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 623/638
(97 %)
0 diff
(100 %id)
CD368763 Alveolar Macrophage, lung .a 7214 to 7837 638 to 16   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 623/638
(97 %)
0 diff
(100 %id)
BF874154 lung_tumor .a 7226 to 7522 1 to 296       296/302
(98 %)
4 diff
(98.7 %id)
W32118 parathyroid gland, parathyroid tumor .a 7233 to 7468 1 to 237   fully sequenced,   237/237
(100 %)
5 diff
(97.9 %id)
AA176112   .a 7234 to 7834 606 to 1       606/610
(99 %)
9 diff
(98.6 %id)
AI819116 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 7248 to 7834 588 to 1       588/588
(100 %)
1 diff
(99.9 %id)
DB366952   .a 7254 to 7834 576 to 1       576/594
(96 %)
8 diff
(98.7 %id)
AA327229 colon .a 7263 to 7609 1 to 349       349/349
(100 %)
3 diff
(99.2 %id)
CB159617 Liver .a 7263 to 7828 1 to 566       566/566
(100 %)
0 diff
(100 %id)
FN082440 breast carcinoma .a 7279 to 7360 84 to 1     Submitted on the opposite strand 84/85
(98 %)
7 diff
(91.8 %id)
AI583182 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 7280 to 7836 557 to 1       557/557
(100 %)
0 diff
(100 %id)
BF434945 Kidney .a 7292 to 7836 547 to 1       547/547
(100 %)
2 diff
(99.7 %id)
BM996650 lung, Metastatic Chondrosarcoma .a 7299 to 7837 553 to 16   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 538/553
(97 %)
0 diff
(100 %id)
AW134519   .a 7300 to 7837 552 to 15   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 538/552
(97 %)
0 diff
(100 %id)
R22252 placenta .a 7302 to 7556 1 to 263   fully sequenced,   263/263
(100 %)
6 diff
(97.8 %id)
BF438363 Prostate .a 7302 to 7834 533 to 1       533/533
(100 %)
0 diff
(100 %id)
CU445021 epidermis .a 7304 to 7795 17 to 508       492/526
(93 %)
1 diff
(99.9 %id)
AI628367 Kidney .a 7304 to 7834 531 to 1       531/531
(100 %)
0 diff
(100 %id)
AI478195 Kidney .a 7308 to 7834 527 to 1       527/527
(100 %)
0 diff
(100 %id)
AI394104 B-cell, chronic lymphotic leukemia .a 7311 to 7833 523 to 1       523/523
(100 %)
5 diff
(99.1 %id)
AA020980 eye, retina .a 7323 to 7834 518 to 1       518/518
(100 %)
6 diff
(98.9 %id)
CA943666 Pancreas, Purified pancreatic islet .a 7330 to 7834 516 to 12   AAA   505/505
(100 %)
3 diff
(99.5 %id)
AW614605 Kidney .a 7331 to 7834 504 to 1       504/504
(100 %)
2 diff
(99.7 %id)
FN098999 breast carcinoma .a 7334 to 7398 1 to 68       68/69
(98 %)
2 diff
(97.2 %id)
BE045533 carcinoid, lung .a 7338 to 7834 497 to 1       497/497
(100 %)
5 diff
(99.0 %id)
BP395892 pancreatic islet .a 7339 to 7837 1 to 504     Submitted on the opposite strand 504/505
(99 %)
9 diff
(98.3 %id)
AI768078 colon, colon tumor, RER+ .a 7339 to 7835 496 to 1       496/496
(100 %)
3 diff
(99.4 %id)
FN053561 breast carcinoma .a 7341 to 7408 1 to 68       68/68
(100 %)
3 diff
(95.6 %id)
BG235913 blood, lymphocyte .a 7341 to 7837 499 to 3       497/499
(99 %)
0 diff
(100 %id)
BP394771 pancreatic islet .a 7342 to 7837 1 to 496     Submitted on the opposite strand 496/499
(99 %)
1 diff
(99.8 %id)
BG057364 blood, lymphocyte .a 7345 to 7830 490 to 5       486/490
(99 %)
0 diff
(100 %id)
BP394621 pancreatic islet .a 7347 to 7837 1 to 492     Submitted on the opposite strand 492/495
(99 %)
2 diff
(99.6 %id)
AA101252 brain, neuroepithelial cells .a 7349 to 7836 490 to 1       490/490
(100 %)
2 diff
(99.6 %id)
FN149983 breast carcinoma .a 7353 to 7445 1 to 93       93/93
(100 %)
1 diff
(99.0 %id)
FN136770 breast carcinoma .a 7360 to 7452 94 to 1     Submitted on the opposite strand 94/94
(100 %)
1 diff
(99.0 %id)
AI830602 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 7362 to 7833 472 to 1       472/472
(100 %)
1 diff
(99.8 %id)
AI628409 Kidney .a 7363 to 7834 473 to 2       472/473
(99 %)
0 diff
(100 %id)
AI675294 Prostate .a 7364 to 7837 483 to 10   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 474/483
(98 %)
0 diff
(100 %id)
AI810299 Prostate .a 7367 to 7837 472 to 3       470/472
(99 %)
0 diff
(100 %id)
AI438987 B-cell, chronic lymphotic leukemia .a 7368 to 7837 471 to 3       469/471
(99 %)
0 diff
(100 %id)
AA026878 uterus .a 7369 to 7618 1 to 250       250/250
(100 %)
1 diff
(99.6 %id)
BF062954 colon, colon tumor, RER+ .a 7371 to 7834 464 to 1       464/464
(100 %)
1 diff
(99.8 %id)
AA733134 heart .a 7374 to 7835 458 to 1       458/458
(100 %)
5 diff
(99.0 %id)
BX377034 Placenta Cot 25-normalized .a 7376 to 7820 446 to 1       446/453
(98 %)
11 diff
(97.6 %id)
AI890121 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 7392 to 7837 457 to 12   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 446/457
(97 %)
1 diff
(99.8 %id)
AI671411 Kidney .a 7394 to 7834 441 to 1       441/441
(100 %)
2 diff
(99.6 %id)
H99145 melanocyte .a 7410 to 7834 430 to 1       430/432
(99 %)
12 diff
(97.3 %id)
AA581997 germ cell tumor .a 7426 to 7834 409 to 1       409/409
(100 %)
0 diff
(100 %id)
AI862828 lymph node, lymphoma, follicular mixed small and largecell .a 7435 to 7835 401 to 1       401/401
(100 %)
1 diff
(99.8 %id)
AA857679 epithelium (cell line), Prostate .a 7439 to 7835 398 to 1       398/398
(100 %)
1 diff
(99.8 %id)
AI866902 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 7441 to 7836 395 to 1       395/395
(100 %)
1 diff
(99.8 %id)
H97045 melanocyte .a 7445 to 7834 391 to 1       391/391
(100 %)
2 diff
(99.5 %id)
BP398248 pancreatic islet .a 7449 to 7834 1 to 387     Submitted on the opposite strand 387/387
(100 %)
2 diff
(99.5 %id)
W31626 parathyroid gland, parathyroid tumor .a 7453 to 7834 385 to 1   fully sequenced,   385/385
(100 %)
7 diff
(98.2 %id)
AA465732.
matches multiple genes
germinal center B cell .a 7453 to 7835 383 to 1     also hits gene gawmuby 383/383
(100 %)
0 diff
(100 %id)
AW993754 breast_normal .a 7465 to 7821 379 to 24     Submitted on the opposite strand 356/379
(93 %)
0 diff
(100 %id)
BF593013 Kidney .a 7474 to 7834 361 to 1       361/361
(100 %)
2 diff
(99.5 %id)
EC558695 Prostate .a 7475 to 7599 1 to 125       125/125
(100 %)
6 diff
(95.2 %id)
AA731664 germinal center B cell .a 7480 to 7837 365 to 7       359/365
(98 %)
0 diff
(100 %id)
AA974904 2 pooled tumors (clear cell type), Kidney .a 7480 to 7839 362 to 3       360/362
(99 %)
0 diff
(100 %id)
AA494109 colon .a 7482 to 7835 354 to 1       354/354
(100 %)
1 diff
(99.8 %id)
AW881857 ovary .a 7490 to 7679 1 to 190       190/234
(81 %)
6 diff
(97.5 %id)
FN147827 breast carcinoma .a 7492 to 7563 1 to 71       71/72
(98 %)
2 diff
(97.3 %id)
BF476028 Prostate .a 7492 to 7834 343 to 1       343/343
(100 %)
0 diff
(100 %id)
BM837468 Ascites, stomach .a 7495 to 7837 356 to 14   AAA Submitted on the opposite strand 343/356
(96 %)
0 diff
(100 %id)
AI811317 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 7499 to 7837 344 to 6       339/347
(97 %)
0 diff
(100 %id)
BM703521 eye, human retina .a 7499 to 7837 1 to 339   fully sequenced, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 339/339
(100 %)
1 diff
(99.8 %id)
AI338111 lung .a 7503 to 7837 344 to 10   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 335/344
(97 %)
0 diff
(100 %id)
AA291168 germinal center B cell .a 7514 to 7837 327 to 4       324/327
(99 %)
0 diff
(100 %id)
AI200103 placenta .a 7516 to 7839 331 to 8       324/331
(97 %)
0 diff
(100 %id)
R77963 placenta .a 7518 to 7812 297 to 1       297/297
(100 %)
2 diff
(99.4 %id)
AA731663 germinal center B cell .a 7520 to 7837 324 to 7       318/324
(98 %)
0 diff
(100 %id)
TI_149280738   .a 7521 to 7837 390 to 74   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 317/775
(40 %)
0 diff
(100 %id)
BU679364 lung, Primary Lung Epithelial Cells .a 7521 to 7837 332 to 16   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 317/347
(91 %)
0 diff
(100 %id)
CB068521 Pancreas, Purified pancreatic islet .a 7522 to 7836 315 to 1       315/315
(100 %)
4 diff
(98.8 %id)
R22198 placenta .a 7526 to 7836 313 to 1   fully sequenced,   313/313
(100 %)
2 diff
(99.4 %id)
BM990709 lung, Lung Focal Fibrosis .a 7526 to 8168 18 to 657   tiling clone, Submitted on the opposite strand 640/657
(97 %)
6 diff
(99.1 %id)
CB242838 Human Lung Epithelial cells, lung .a 7527 to 7837 1 to 311   AAA Submitted on the opposite strand 311/320
(97 %)
2 diff
(99.4 %id)
CB068559 Pancreas, Purified pancreatic islet .a 7537 to 7836 300 to 1   fully sequenced,   300/300
(100 %)
0 diff
(100 %id)
AA216611 brain, neuroepithelial cells .a 7543 to 7834 296 to 1       296/296
(100 %)
4 diff
(98.7 %id)
BP395203 pancreatic islet .a 7550 to 7814 1 to 266     Submitted on the opposite strand 266/266
(100 %)
7 diff
(97.4 %id)
AI581618 colon .a 7558 to 7834 279 to 1       279/279
(100 %)
5 diff
(98.3 %id)
FN144715 breast carcinoma .a 7575 to 7682 1 to 109       109/109
(100 %)
2 diff
(98.2 %id)
H43598 breast .a 7579 to 7817 257 to 18       240/257
(93 %)
0 diff
(100 %id)
AA730560 Ewing's sarcoma .a 7601 to 7837 239 to 2       238/239
(99 %)
0 diff
(100 %id)
FN158390 breast carcinoma .a 7607 to 7708 1 to 99       99/107
(92 %)
3 diff
(97.2 %id)
BM751145 Ascites, stomach .a 7607 to 7837 234 to 4     Submitted on the opposite strand 231/234
(98 %)
0 diff
(100 %id)
AI472513 colon, moderately-differentiated adenocarcinoma .a 7630 to 7835 208 to 1       208/208
(100 %)
2 diff
(99.1 %id)
FN155427 breast carcinoma .a 7669 to 7805 1 to 135       135/135
(100 %)
2 diff
(98.6 %id)
C75353   .a 7683 to 7837 158 to 4       155/158
(98 %)
0 diff
(100 %id)
C01240   .a 7698 to 7834 1 to 137       137/137
(100 %)
1 diff
(99.3 %id)
AA978055 2 pooled tumors (clear cell type), Kidney .a 7710 to 7839 132 to 3       130/132
(98 %)
0 diff
(100 %id)
BU729432 eye, human retina .a 7768 to 7843 85 to 10   fully sequenced, Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 76/85
(89 %)
5 diff
(94.2 %id)
BI018697 marrow .a 8076 to 8477 1 to 402   tiling clone,   402/402
(100 %)
4 diff
(99.1 %id)
AY280966 gastric .b 1 to 2329 1 to 2329 A110V M644T tiling clone,   2329/2329
(100 %)
3 diff
(99.9 %id)
AF368294   .c 14 to 2125 1 to 2112       2112/2112
(100 %)
21 diff
(99.1 %id)
BC077720 Lung, epidermoid carcinoma .c 14 to 3316 1 to 3303   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 3303/3303
(100 %)
0 diff
(100 %id)
DQ236342   .c 14 to 2125 1 to 2112       2112/2112
(100 %)
3 diff
(99.9 %id)
AK291781 placenta .c 411 to 2408 425 to 2422 M564T     2422/2422
(100 %)
2 diff
(100.0 %id)
NM_025151.4   .c 411 to 5937 428 to 5954 exact RefSeq,   5954/5954
(100 %)
0 diff
(100 %id)
AK092296 tongue .c 676 to 3326 1 to 2651   tiling clone, available from FLJ,   2651/2651
(100 %)
3 diff
(99.9 %id)
AX747459   .c 676 to 3326 1 to 2651       2651/2651
(100 %)
3 diff
(99.9 %id)
DA834224 placenta .c 1012 to 1756 2 to 752   capped   751/821
(91 %)
12 diff
(98.6 %id)
TI_154152211   .c 1216 to 1769 72 to 624       553/556
(99 %)
23 diff
(95.9 %id)
DA043504 bladder .c 1231 to 1798 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
CN346609 embryonic stem cells, cell lines H1, H7, andH9 .c 1255 to 1758 1 to 504       504/504
(100 %)
0 diff
(100 %id)
BX283867 eye, retinoblastoma .c 1298 to 1802 1 to 505       505/505
(100 %)
3 diff
(99.5 %id)
BE254624 eye, retinoblastoma .c 1318 to 1935 1 to 619       619/619
(100 %)
3 diff
(99.6 %id)
DB227110 trachea .c 1351 to 1920 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BY997428   .c 1461 to 2134 9 to 682       674/682
(98 %)
8 diff
(98.9 %id)
CN346608 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1480 to 2184 1 to 706       706/706
(100 %)
4 diff
(99.5 %id)
BX481166   .c 1551 to 2009 1 to 459       459/459
(100 %)
5 diff
(99.0 %id)
BG950012 breast_normal .c 1558 to 1739 1 to 183       183/183
(100 %)
13 diff
(92.9 %id)
AW816534 stomach .c 1559 to 1802 1 to 248       248/248
(100 %)
8 diff
(96.8 %id)
BI047402 stomach .c 1566 to 1773 220 to 13       208/220
(94 %)
1 diff
(99.6 %id)
CN346610 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 1649 to 2388 1 to 739       739/739
(100 %)
1 diff
(99.9 %id)
DB381354 placenta .c 5370 to 5932 564 to 1   tiling clone,   564/567
(99 %)
7 diff
(98.8 %id)
AY367050   .d 1 to 1959 1 to 1959 Q53K A82V M616T tiling clone,   1959/1959
(100 %)
4 diff
(99.8 %id)
H85287 melanocyte .d 1825 to 2187 367 to 1   tiling clone, Submitted on the opposite strand 367/388
(94 %)
6 diff
(98.5 %id)
AY280967   .e-u 1 to 2892 1 to 2892 Q81K A110V Q173H A457V tiling clone,   2892/2892
(100 %)
9 diff
(99.7 %id)
BQ360034 head_normal .f 1 to 449 7 to 452   tiling clone,   446/461
(96 %)
6 diff
(98.7 %id)
BQ337432 marrow .f 36 to 439 1 to 409       409/409
(100 %)
12 diff
(97.1 %id)
AY280969 gastric .f 146 to 3223 1 to 3078 A110V H514Y tiling clone,   3078/3078
(100 %)
6 diff
(99.9 %id)
BI013987 lung_tumor .f 2116 to 2470 12 to 367   tiling clone,   356/367
(97 %)
6 diff
(98.4 %id)
AW999052 breast_normal .f 2664 to 2984 320 to 1     Submitted on the opposite strand 320/324
(98 %)
11 diff
(96.7 %id)
BF327153 breast_normal .f 2676 to 2972 313 to 16       298/317
(94 %)
0 diff
(100 %id)
DQ083995 stomach .g 1 to 1866 1 to 1866 M403T tiling clone,   1866/1866
(100 %)
2 diff
(99.9 %id)
AY280970   .h 1 to 1959 1 to 1953 D334G tiling clone,   1953/1953
(100 %)
6 diff
(99.7 %id)
BF760205 colon .h 429 to 825 1 to 394   tiling clone,   394/394
(100 %)
7 diff
(98.3 %id)
AK124212 thymus .i-u 1 to 2058 2 to 2058   tiling clone, available from FLJ,   2058/2060
(99 %)
19 diff
(99.1 %id)
DB127924 thymus .i-u 1 to 558 2 to 560   capped   559/559
(100 %)
16 diff
(97.2 %id)
BF849466 lung_normal .i-u 367 to 615 254 to 5   tiling clone, Submitted on the opposite strand 250/255
(98 %)
30 diff
(88.3 %id)
BF850483 lung_normal .i-u 439 to 588 158 to 7   tiling clone, Submitted on the opposite strand 152/162
(93 %)
0 diff
(100 %id)
AI871739 carcinoid, lung .i-u 474 to 818 345 to 1       345/345
(100 %)
3 diff
(99.2 %id)
DB344394 thymus .i-u 1586 to 2058 475 to 3       473/477
(99 %)
0 diff
(100 %id)
BF899180 marrow .i-u 1854 to 2109 1 to 254       254/254
(100 %)
5 diff
(98.1 %id)
BF899164 marrow .i-u 1857 to 2109 1 to 251   tiling clone,   251/251
(100 %)
3 diff
(98.9 %id)
AK124422 bladder .i-u 2063 to 5406 1 to 3340 C39Y tiling clone, available from FLJ,   3340/3340
(100 %)
15 diff
(99.6 %id)
DA043787 bladder .i-u 2064 to 2635 2 to 570   capped   569/569
(100 %)
15 diff
(97.4 %id)
BF906916 stomach .i-u 2495 to 2739 31 to 271       241/272
(88 %)
12 diff
(95.6 %id)
DB296084 bladder .i-u 4877 to 5406 530 to 1       530/533
(99 %)
0 diff
(100 %id)
BI028765 marrow .j-u 1 to 326 1 to 325 R12G E13R K14R E15K G16A ... tiling clone,   325/360
(90 %)
7 diff
(98.1 %id)
BF174554 blood .j-u 172 to 545 1 to 370   tiling clone,   370/370
(100 %)
7 diff
(98.2 %id)
BU685767 lung, Primary Lung Epithelial Cells Gene RAB11FIP1, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AV733984 pheochromocytoma Gene RAB11FIP1, variant not shown         Suspected internal deletion, this clone was ignored    
BE081088 breast Gene RAB11FIP1, variant not shown         This clone was ignored    
BE243311 leukopheresis Gene RAB11FIP1, variant not shown              
BP262009 small intestine Gene RAB11FIP1, variant not shown         Suspected internal deletion, this clone was ignored    
DB166547 thyroid gland Gene RAB11FIP1, variant not shown       capped This clone was ignored    
DB382628 thyroid gland Gene RAB11FIP1, variant not shown         This clone was ignored    
AK090437 Spleen Gene RAB11FIP1, variant not shown       available from FLJ, This clone was ignored    
AK026275 human small intestine Gene RAB11FIP1, variant not shown       available from FLJ, AAA Suspected internal deletion, this clone was ignored    
DW421289 Liver Gene RAB11FIP1, variant not shown         This clone was ignored    
AI394594 B-cell, chronic lymphotic leukemia Gene RAB11FIP1, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
BF439077 pooled Gene RAB11FIP1, variant not shown         Submitted on the opposite strand    
BI260525 cervical carcinoma cell line, cervix Gene RAB11FIP1, variant not shown         Submitted on the opposite strand    
TI_149300290   Gene RAB11FIP1, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e-u, .f, .g, .h, .i-u, .j-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI